Del. Judge May Have Mallinckrodt Choose: Injunction Or $10M

By Dani Kass · October 8, 2025, 7:30 PM EDT

A Delaware federal judge said he might ask Mallinckrodt Pharmaceuticals to choose between getting a competitor's inhaled nitric oxide treatment enjoined, or receiving the entire $9.5 million a jury determined it's...

To view the full article, register now.

Documents

Case Information

Case Title

Mallinckrodt Pharmaceuticals Ireland Limited et al v. Airgas Therapeutics LLC et al

Case Number

1:22-cv-01648

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

December 30, 2022